1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Craving: new trials by email Literature Review of Craving trials Research Report on Craving
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder CBOT + TAU, Sham + TAU - Opioid Use Disorder, Moderate, Opioid Use Disorder, Severe | Phase 2 | Unknown | Evon Medics LLC | 190 | 2021-03-26 | 2021-08-06 |
Lymphoma, Follicular (1) · Opioid-Related Disorders (1) · Substance Withdrawal Syndrome (1)
Chemically-Induced Disorders (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Mental Disorders (1) · Narcotic-Related Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Substance-Related Disorders (1)
Evon Medics LLC (1)
United States (1)
Edwin Chapman, MD (1) · Evaristus A Nwulia, MD (1) · Marc Fishman, MD (1) · Mark Johnson, MD (1) · Michael Serlin, MD (1) · Tanya Alim, MD (1)
R44DA049616 (1)